Infused Total Nucleated Cell Dose is a Better Predictor of Transplant Outcomes Than CD34+ Cell Dose for Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Children

被引：0
|
作者：
Wells, Joseph Russell [1 ]
Sunkara, Anusha [2 ]
Kang, Guolian [2 ]
Hale, Jennifer [1 ]
Hughes, Carlton [1 ]
Alloush, Lina [1 ]
Madden, Renee [1 ]
Qudeimat, Amr [1 ]
Mamcarz, Ewelina [1 ]
Leung, Wing H. [1 ]
Janssen, William [1 ]
Triplett, Brandon M. [1 ]
Srinivasan, Ashok [1 ]
机构：
[1] St Jude Childrens Res Hosp, Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
582
引用
收藏
页码：S396 / S397
页数：2
相关论文
共 50 条
  • [21] Infused Total Nucleated Cell Dose is not Associated with Engraftment in Autologous Stem Cell Transplantation
    Merchionne, Francesca
    Spina, Alessandro
    Coppi, Maria Rosaria
    Mele, Giuseppe
    Quintana, Giovanni
    Cucci, Francesco
    Miccoli, Antonella
    Gatto, Vincenzo
    Belardi, Antonio
    Pastore, Domenico
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 416 - 417
  • [22] Impact of transplanted CD34+cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    Sohn, SK
    Kim, JG
    Kim, DH
    Lee, NY
    Suh, JS
    Lee, KB
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 967 - 972
  • [23] Optimal CD34+ cell dose in autologous peripheral-blood stem-cell transplantation -: In reply
    Siena, S
    Schiavo, R
    Sartore-Bianchi, A
    Pedrazzoli, P
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3319 - 3320
  • [24] Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy
    Siena, S
    Schiavo, R
    Pedrazzoli, P
    Carlo-Stella, C
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1360 - 1377
  • [25] Impact of CD34+ Stem Cell Dose on Engraftment Period in Allogeneic Peripheral Blood Stem Cell Transplanted Patients
    Suria, A. A.
    Diyana, Hazlina B.
    Zakari, Zed A. H.
    Nurasyikin, Y.
    Yousuf, R.
    Azma, R. Z.
    MEDICINE AND HEALTH, 2021, 16 (01): : 39 - 49
  • [26] Association of CD34+Cell Dose with Progression-free Survival after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation in Children with Hematologic Malignancies
    Wang, Yi-Lun
    Chang, Tsung-Yen
    Hsieh, Hsin-Yi
    Chen, Shih-Hsiang
    Wen, Yu-Chuan
    Chiu, Chia-Chi
    Jaing, Tang-Her
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (02) : 481 - 484
  • [27] Allogeneic graft CD34+ cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant
    Urbini, B
    Arpinati, M
    Bonifazi, F
    Chirumbolo, G
    Falcioni, S
    Stanzani, M
    Bandini, G
    Motta, MR
    Perrone, G
    Giannini, B
    Tura, S
    Baccarani, M
    Rondelli, D
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (10) : 959 - 965
  • [28] Impact of transplant CD34+cell dose on outcomes after allogeneic peripheral blood stem cell transplantation from a matched unrelated donor.
    Nakamura, R
    Smith, D
    Parker, P
    Senitzer, D
    Rodriguez, R
    Falk, P
    Fung, H
    Kirschbaum, M
    Kogut, N
    Krishnan, A
    O'Donnell, MR
    Popplewell, L
    Pullarkat, V
    Sahebi, F
    Smith, E
    Snyder, D
    Spielberger, R
    Stein, A
    Zain, J
    Forman, SJ
    Nademanee, A
    BLOOD, 2003, 102 (11) : 488A - 488A
  • [29] Effect of CD34+cell dose on clinical outcomes after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Pedraza, A.
    Salas, M. Q.
    Rodriguez-Lobato, L. G.
    Charry, P.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Domenech, A.
    Solano, M. T.
    Arcarons, J.
    Llobet, N.
    Cid, J.
    Lozano, M.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    Rovira, M.
    Martinez, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 400 - 400
  • [30] Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    Pérez-Simón, JA
    Díez-Campelo, M
    Martino, R
    Sureda, A
    Caballero, D
    Cañizo, C
    Brunet, S
    Altes, A
    Vazquez, L
    Sierra, J
    San Miguel, JF
    BLOOD, 2003, 102 (03) : 1108 - 1113
12345